Apixaban

📋 Product Overview Table

🧬 What is Apigat (Apixaban)?

Apigat, manufactured by Natco Pharma Ltd., is a trusted Indian generic of Eliquis, containing the active ingredient Apixaban. It is a modern direct oral anticoagulant (DOAC) used to prevent blood clots and reduce the risk of stroke in patients with non-valvular atrial fibrillation (AFib). It’s also effective in the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Apigat offers a significant advantage over traditional anticoagulants like Warfarin due to less dietary restriction, fewer drug interactions, and no need for regular INR monitoring. It is available in 2.5 mg and 5 mg strengths, depending on the patient’s clinical need and renal function.

🎬 Educational Video Placeholder

🩺 Doctor’s Expert Commentary

Dr. Nikhil Suresh, Cardiologist:
“Apixaban is a breakthrough in anticoagulation therapy. Its predictable pharmacokinetics and lower bleeding risk profile make it a suitable alternative to Warfarin for many patients. Natco’s Apigat provides an affordable and clinically reliable version for global use.”

💉 Dosage & Administration

Dosage may vary based on renal function, age, and weight. Consult your physician.

⚠️ Side Effects, Warnings & Storage

• Common Side Effects: Minor bleeding, bruising, nausea
• Serious Risks: Major bleeding, hypersensitivity, spinal/epidural hematoma
• Precautions: Not advised with other anticoagulants or in active bleeding conditions
• Storage: Store below 30°C in a dry, cool place away from sunlight

🌍 Global Availability

🔗 Related Indian Alternatives (Same Therapeutic Class)

📚 Trusted Medical References

• Drugs.com – Apixaban
• NHS – Anticoagulants Overview
• WHO Essential Medicines List

⚠️ Medical Disclaimer
This content is intended for educational purposes only and does not replace the advice of a licensed physician. Always consult your doctor before starting or stopping any medication.